Daisuke Nakai

3.5k total citations
85 papers, 2.7k citations indexed

About

Daisuke Nakai is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Daisuke Nakai has authored 85 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Daisuke Nakai's work include Drug Transport and Resistance Mechanisms (24 papers), Pharmacological Effects and Toxicity Studies (10 papers) and HIV/AIDS drug development and treatment (6 papers). Daisuke Nakai is often cited by papers focused on Drug Transport and Resistance Mechanisms (24 papers), Pharmacological Effects and Toxicity Studies (10 papers) and HIV/AIDS drug development and treatment (6 papers). Daisuke Nakai collaborates with scholars based in Japan, Germany and Sweden. Daisuke Nakai's co-authors include Takaaki Abe, Taro Tokui, Rie Nakagomi, Hiromu Yawo, Toshiyuki Nishio, Takeshi Naitoh, Masayuki Kakyo, Masanori Suzuki, Michiaki Unno and Seiki Matsuno and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Daisuke Nakai

84 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Nakai Japan 25 1.2k 756 553 526 496 85 2.7k
Markus Grube Germany 34 1.7k 1.4× 785 1.0× 810 1.5× 315 0.6× 277 0.6× 71 3.3k
Ming Zheng United States 39 2.7k 2.2× 1.8k 2.3× 250 0.5× 823 1.6× 449 0.9× 169 6.7k
Shogo Ozawa Japan 42 2.1k 1.7× 2.1k 2.8× 763 1.4× 550 1.0× 1.6k 3.3× 177 5.3k
Edward J. Kelly United States 35 643 0.5× 1.1k 1.5× 429 0.8× 218 0.4× 556 1.1× 96 3.5k
Gary Gordon United States 35 1.0k 0.8× 1.4k 1.9× 195 0.4× 255 0.5× 294 0.6× 105 4.4k
Dominic P. Williams United Kingdom 44 681 0.6× 1.6k 2.1× 207 0.4× 259 0.5× 2.0k 4.0× 106 5.4k
Christophe Chesné France 31 513 0.4× 802 1.1× 107 0.2× 648 1.2× 718 1.4× 80 3.0k
Yaning Wang United States 29 591 0.5× 769 1.0× 559 1.0× 101 0.2× 547 1.1× 117 3.4k

Countries citing papers authored by Daisuke Nakai

Since Specialization
Citations

This map shows the geographic impact of Daisuke Nakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Nakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Nakai more than expected).

Fields of papers citing papers by Daisuke Nakai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Nakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Nakai. The network helps show where Daisuke Nakai may publish in the future.

Co-authorship network of co-authors of Daisuke Nakai

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Nakai. A scholar is included among the top collaborators of Daisuke Nakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Nakai. Daisuke Nakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Saito, Keiji, Akira Nakao, Tomonori Kunikata, et al.. (2021). Discovery of 3-amino-4-{(3S)-3-[(2-ethoxyethoxy)methyl]piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxamide (DS96432529): A potent and orally active bone anabolic agent. Bioorganic & Medicinal Chemistry Letters. 54. 128440–128440. 2 indexed citations
4.
Matsui, Yumi, Takahiro Yamaguchi, Takanori Yamazaki, et al.. (2015). Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists. Bioorganic & Medicinal Chemistry Letters. 25(18). 3914–3920. 13 indexed citations
5.
6.
Murai, Takahiro, Hideo Takakusa, Daisuke Nakai, et al.. (2014). Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats. Xenobiotica. 44(11). 996–1008. 11 indexed citations
7.
Yamamoto, Yoshimasa, et al.. (2010). Latitudinal Gradient in the Body Weight of Bluegill Lepomis macrochirus in Lake Biwa, Japan. Zoological studies. 49(5). 625–631. 8 indexed citations
8.
Yamamoto, Yoshimasa & Daisuke Nakai. (2009). Monitoring Individual Growth of Tilapia (Oreochromis niloticus and Tilapia zillii) in An Artificially Heated River. 57(1). 109–116. 2 indexed citations
9.
Maekawa, Toshio, Seungjoon Kim, Daisuke Nakai, et al.. (2009). Social isolation stress induces ATF‐7 phosphorylation and impairs silencing of the 5‐HT 5B receptor gene. The EMBO Journal. 29(1). 184–195. 54 indexed citations
10.
Ijiri, Hiroshi, Fasséli Coulibaly, Daisuke Nakai, et al.. (2009). Structure-based targeting of bioactive proteins into cypovirus polyhedra and application to immobilized cytokines for mammalian cell culture. Biomaterials. 30(26). 4297–4308. 52 indexed citations
11.
Nakai, Daisuke, et al.. (2007). Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1. Xenobiotica. 37(5). 474–486. 49 indexed citations
12.
Koizumi, Makoto, Ryo Okuyama, Kazushi Araki, et al.. (2006). Direct Comparison of In Vivo Antisense Activity of ENA Oligonucleotides Targeting PTP1B mRNA with That of 2'- O -(2-Methoxy)ethyl-Modified Oligonucleotides. Oligonucleotides. 16(3). 253–262. 11 indexed citations
13.
Nakai, Daisuke, et al.. (2004). Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method. Journal of Pharmaceutical Sciences. 93(4). 847–854. 72 indexed citations
14.
Nakai, Daisuke, Takahiko Shimizu, Hidetoshi Nojiri, et al.. (2004). coq7/clk‐1 regulates mitochondrial respiration and the generation of reactive oxygen species via coenzyme Q. Aging Cell. 3(5). 273–281. 28 indexed citations
15.
Nakai, Daisuke, Shigeki Yuasa, Mayumí Takáhashi, et al.. (2001). Mouse Homologue of coq7/clk-1, Longevity Gene in Caenorhabditis elegans, Is Essential for Coenzyme Q Synthesis, Maintenance of Mitochondrial Integrity, and Neurogenesis. Biochemical and Biophysical Research Communications. 289(2). 463–471. 69 indexed citations
16.
Takáhashi, Mayumí, Sunao Asaumi, Shuji Honda, et al.. (2001). Mouse coq7/clk-1 Orthologue Rescued Slowed Rhythmic Behavior and Extended Life Span of clk-1 Longevity Mutant in Caenorhabditis elegans. Biochemical and Biophysical Research Communications. 286(3). 534–540. 14 indexed citations
17.
Nakai, Daisuke, Rie Nakagomi, Yoshitake Furuta, et al.. (2001). Human Liver-Specific Organic Anion Transporter, LST-1, Mediates Uptake of Pravastatin by Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 297(3). 861–867. 178 indexed citations
18.
Abe, Takaaki, Masayuki Kakyo, Taro Tokui, et al.. (1999). Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1. Journal of Biological Chemistry. 274(24). 17159–17163. 437 indexed citations
19.
Kakyo, Masayuki, Michiaki Unno, Taro Tokui, et al.. (1999). Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1. Gastroenterology. 117(4). 770–775. 85 indexed citations
20.
Tokui, Taro, Daisuke Nakai, Rie Nakagomi, et al.. (1999). Pravastatin, an HMG-CoA Reductase Inhibitor, Is Transported by Rat Organic Anion Transporting Polypeptide, oatp2. Pharmaceutical Research. 16(6). 904–908. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Grube Breakdown of academic impact, for papers by Ming Zheng Breakdown of academic impact, for papers by Shogo Ozawa Breakdown of academic impact, for papers by Edward J. Kelly Breakdown of academic impact, for papers by Gary Gordon Breakdown of academic impact, for papers by Dominic P. Williams Breakdown of academic impact, for papers by Christophe Chesné Breakdown of academic impact, for papers by Yaning Wang
Rankless by CCL
2026